Hosted on MSN
Novo Nordisk's Wegovy pill sets US launch record
Record-breaking debut: Wegovy's oral form reached over two million US prescriptions in 16 weeks, generating $360 million in Q1 revenue. Competitive landscape: Eli Lilly's Foundayo entered the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results